These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18523971)

  • 1. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Xu CP; Chen DL; Zhang R; Wang JM; Bian XW
    J Pathol; 2008 Aug; 215(4):369-76. PubMed ID: 18523971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
    Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
    J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
    Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
    J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
    Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
    Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
    Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of nordy on FPR function of malignant human glioma cell line U87].
    Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
    Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
    Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
    Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
    Chen JH; Yao XH; Gong W; Hu J; Zhou XD; Chen K; Liu H; Ping YF; Wang JM; Bian XW
    J Neurooncol; 2007 Sep; 84(3):223-31. PubMed ID: 17377739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
    Huang J; Chen K; Chen J; Gong W; Dunlop NM; Howard OM; Gao Y; Bian XW; Wang JM
    Br J Cancer; 2010 Mar; 102(6):1052-60. PubMed ID: 20197768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
    Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
    Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
    Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
    Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
    Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
    PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.
    Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S
    Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.